Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders

/PRNewswire/ -- Coave Therapeutics ('Coave'), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS (Central...

Related Keywords

Paris ,France General ,France ,Clerval ,Franche Comtér ,French ,Eleanor Perkin ,Sylvie Berrebi ,Andrea Ballabio ,Linkedin ,University Of Bordeaux ,French National Centre Of Scientific Research ,Institute Of Neurodegenerative Diseases ,Telethon Institute Of Genetics ,Seroba Life Sciences ,Central Nervous System ,Neurodegenerative Diseases ,French National Centre ,Scientific Research ,Multiple System Atrophy ,Scientific Advisory Board ,Scientific Director ,Telethon Institute ,Ligand Conjugate ,Research Director ,Multiple System ,Rodolphe Clerval ,Autophagy Lysosomal Pathway ,Open Innovation ,Omnes Capital ,V Bio Ventures ,Kurma Partners ,Sham Innovation Sant ,Mark Swallow ,Coave Therapeutics ,